Pulse Biosciences, Inc. PLSE Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $80.74M-31.6% | $118.04M+166% | $44.37M-27.4% | $61.14M+37.8% | ||
| —— | —— | $0-100% | $34K-79.2% | ||
| $274K— | $0— | $0-100% | $16.11M+15.6% | ||
| $83.42M-30.2% | $119.45M+164% | $45.33M-27.1% | $62.15M+37.1% | ||
| $1.05M-9.4% | $1.16M-24.1% | $1.53M-22.1% | $1.96M+28.3% | ||
| $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | $2.79M0.0% | ||
| $575K-52.9% | $1.22M-35.3% | $1.89M-26.1% | $2.55M+35.3% | ||
| $94.54M-28.6% | $132.46M+124% | $59.15M-24.0% | $77.88M+31.7% | ||
| $2.78M+66.0% | $1.67M-8.9% | $1.84M+16.7% | $1.57M-14.3% | ||
| $7.92M-21.2% | $10.06M+49.9% | $6.71M+12.2% | $5.98M-10.8% | ||
| $13.88M-21.1% | $17.6M+19.0% | $14.79M-81.5% | $80.13M— | ||
| $68K+3.0% | $66K+20.0% | $55K+48.6% | $37K-32.7% | ||
| -$463.28M-18.6% | -$390.5M-15.9% | -$336.92M-14.3% | -$294.71M+12.5% | ||
| $80.66M-29.8% | $114.86M+159% | $44.36M+2,073% | -$2.25M-105% | ||
| $94.54M-28.6% | $132.46M+124% | $59.15M-24.0% | $77.88M+31.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Pulse Biosciences, Inc. cover its short-term obligations?
- Its current ratio is 7.26 — current assets exceed current liabilities.
- Where does Pulse Biosciences, Inc.'s balance sheet data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.